Andre Fouquet

Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazoles

Andre Fouquet, Daniel Provost, M. de Cazes et al. · Journal of Medicinal Chemistry · 1992 · 102 citations

Medicinal Chemistry, Novel 2-Arylbenzimidazoles, Cardiovascular Properties +12

Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Dominique Potin, Michèle Launay, Francoise Monatlik et al. · Journal of Medicinal Chemistry · 2006 · 51 citations · Full text

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

Combinatorial Chemistry, Cathepsin K Inhibitors, Medicinal Chemistry +10

2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors

Jiaqiang Cai, David Jonathan Bennett, Zoran Ranković et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 12 citations · Full text

2-Phenyl-9h-purine-6-carbonitrile Derivatives, Medicine, Drug Development +3

Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: Improving selectivity over hERG

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

2-Cyano-pyrimidine Inhibitors, Biochemistry, Medicine +9